Term Name: | oxyphenbutazone |
---|---|
Synonyms: | 1-(p-Hydroxyphenyl)-2-phenyl-4-butyl-3,5-pyrazolidinedione, 1-Phenyl-2-(p-hydroxyphenyl)-3,5-dioxo-4-butylpyrazolidine, 1-Phenyl-2-(p-hydroxyphenyl)-3,5-dioxo-4-n-butylpyrazolidine, 3,5-Dioxo-1-phenyl-2-(p-hydroxyphenyl)-4-N-butylpyrazolidene, 4-Butyl-1-(4-hydroxyphenyl)-2-phenyl-3,5-pyrazolidinedione, 4-Butyl-1-(p-hydroxyphenyl)-2-phenyl-3,5-pyrazolidinedione, 4-Butyl-2-(4-hydroxyphenyl)-1-phenyl-3,5-dioxopyrazolidine, 4-Butyl-2-(p-hydroxyphenyl)-1-phenyl-3,5-pyrazolidinedione, Hydroxyphenylbutazon, Oxi-fenibutol, oxifenbutazona, Oxifenylbutazon, Oxiphenbutazonum, oxyphenbutazone, oxyphenbutazonum, Oxyphenylbutazone, p-Hydroxyphenylbutazone, p-Oxyphenylbutazone |
Definition: | A metabolite of phenylbutazone obtained by hydroxylation at position 4 of one of the phenyl rings. Commonly used (as its hydrate) to treat pain, swelling and stiffness associated with arthritis and gout, it was withdrawn from the market 1984 following association with blood dyscrasis and Stevens-Johnson syndrome. |
Ontology: | ChEBI [CHEBI:76258] ( EBI ) |